Navigation Links
PTC Therapeutics Announces Achievement Of Major Milestone In SMA Collaboration
Date:8/8/2013

SOUTH PLAINFIELD, N.J., Aug. 8, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the selection of a development candidate in its spinal muscular atrophy (SMA) collaboration with Roche and the SMA Foundation. The achievement of the milestone triggers a $10 million payment to PTC from Roche.

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)  

"We are excited about this important achievement in our SMA program", stated Stuart Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics. "This program exemplifies PTC's technology platform and its chemistry and biology expertise applied in an area of great unmet medical need. We are grateful for the exceptional commitment and dedication from our PTC team, as well as from our partners, Roche and the SMA Foundation. The discovery and advancement of a potential new treatment for SMA is a significant milestone for SMA patients and their families."

SMA is caused by a missing or defective SMN1 gene, which results in reduced levels of the survival motor neuron (SMN) protein. It is a genetic neuromuscular disease responsible for the early death of motor neuron cells within the spinal cord leading to muscle atrophy and eventually death in the most severe form of the disease. The oral small molecule compounds in the program target the underlying cause of the disorder by increasing SMN protein levels in the nervous system, muscles, and other tissues. It is estimated that SMA affects approximately 10,000 to 25,000 children and adults in the United States, and that between one in 6,000 and one in 10,000 children are born with this rare disorder.

Luca Santarelli, Head of Neuroscience and Small Molecule Researc
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... According to the new research report  "Digital ... Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide ... published by MarketsandMarkets, analyzes and studies the major market ... North America , Europe , ... the World (RoW). Browse 78 market data ...
(Date:7/29/2014)... July 29, 2014 A new ... market (types, applications and geography) - Size, Share, Global ... Segmentation and Forecast, 2013 - 2020", suggests that the ... billion by 2020 registering a CAGR of 11.1% from ... achieved by the electro surgical devices in operative procedures ...
(Date:7/29/2014)... July 29, 2014 TransVac Solutions, the ... collection and transport solutions for hospitals, will be exhibiting ... Engineering (ASHE) Annual Conference & Technical Exhibition Aug. 3-6 ... its technology for making hospitals cleaner, reducing infection risk ... the hospital’s life cycle. Staff will be available ...
(Date:7/29/2014)... Genera Energy Inc. , a ... supply chain advancements, has announced the deployment of ... and Supply ASSURE™. Both systems were developed ... at consolidating and simplifying the entire process, managing ... feedstock end users. , “Through the Energy Grange ...
Breaking Biology Technology:Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4
... MADISON Has the Wisconsin Economic Summit run its course? ... question that skeptics and supporters alike will ask about the ... economy. , ,The best answer, to be fair, is wait-and-see. ... reminder of what has been accomplished over the past three ...
... Protect Against Wireless Hacking and Rogue Access Point ... the information technology industry's first comprehensive intrusion detection ... breaches on wireless local area networks. , ... security service that melds IBM Global Services' security ...
... many industries tied to the tech sector, the trade show producers ... to be bouncing back, though, and more and more companies are ... , ,Yippee! Good news for trade show booth designers and ... and me who have to go and be trade show slaves ...
Cached Biology Technology:Wisconsin Economic Summit Aims for a New Lease on Life 2IBM Develops Wireless Security Service 2Etiquette at Todays Midwest Technology Trade Show 2Etiquette at Todays Midwest Technology Trade Show 3
(Date:7/29/2014)... In this fascinating journey to the edge of science, ... new book The Beginning and the End: Does our ... it cyclic? Are we alone in the universe? What ... cosmic evolution? Grounded in science and committed to philosophical ... rise of intelligent life is not an accident, but ...
(Date:7/29/2014)... 29, 2014  When it comes to technology, healthcare is usually ... the last. However, when it comes to wearables, healthcare is trying ... for the Internet of Things and its wearable cousins is less ... the healthcare industry, whether it,s in the hospital for a major ... With that in mind, InformationWeek editor Rodney Brown ...
(Date:7/29/2014)... genetics company, has received from the National Institutes ... a two-year project to support the further development ... genetic discovery. , Specifically, the grant supports ... web-based surveys to improve the company,s ability to ... survey tools to support the collection of a ...
Breaking Biology News(10 mins):Book: 'The Beginning and the End' 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3
... COLUMBUS, Ohio Insulin resistance, the hallmark of type ... is paradoxically also an apparent contributor to muscle wasting ... to new research. And in an animal study, ... progression of muscle wasting and fat loss, the main ...
... Biological Sciences Research Council (BBSRC)-funded research, published this week ... discovered molecules that could confuse insects, ability to detect ... could reduce damage to crops by insect pests and ... Hooper of Rothamsted Research, an institute of BBSRC said: ...
... highly complex, research to understand how people fight infection ... simpler organisms. Zebrafish are becoming an important model for ... manipulated and many fundamental processes between zebrafish and humans ... highly amenable to drug screening assays. The functional similarity ...
Cached Biology News:Diabetes drug shows promise in fighting lethal cancer complication 2Diabetes drug shows promise in fighting lethal cancer complication 3Scientists discover how to send insects off the scent of crops 2Fish fend off invading germs with an initial response similar to the one found in people 2
Mouse polyclonal antibody raised against a partial recombinant TSEN2. NCBI Entrez Gene ID = 80746...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
...
Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
Biology Products: